CreoSalus Revenue and Competitors
Estimated Revenue & Valuation
- CreoSalus's estimated annual revenue is currently $4.2M per year.
- CreoSalus's estimated revenue per employee is $279,000
Employee Data
- CreoSalus has 15 Employees.
- CreoSalus grew their employee count by -32% last year.
CreoSalus's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Associate Director, Quality and Compliance | Reveal Email/Phone |
2 | QC Manager | Reveal Email/Phone |
3 | Compliance Manager Biomanufacturing | Reveal Email/Phone |
4 | Assistant Manager QC | Reveal Email/Phone |
5 | Analytical Specialist | Reveal Email/Phone |
6 | Materials Management Specialist | Reveal Email/Phone |
CreoSalus Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.8M | 9 | 0% | N/A | N/A |
What Is CreoSalus?
Biotech company
keywords:Healthcare,Pharmaceuticals
N/A
Total Funding
15
Number of Employees
$4.2M
Revenue (est)
-32%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CreoSalus News
... Constant Therapeutics; CordenPharma; Corvid Pharmaceuticals; Covalab; CPC Scientific; Creative Peptides; CreoSalus; CSBio; CureDM; Curia...
... Constant Therapeutics; CordenPharma; Corvid Pharmaceuticals; Covalab; CPC Scientific; Creative Peptides; CreoSalus; CSBio; CureDM; Curia...
... as well as a pharmaceutical manufacturing facility for CreoSalus in Louisville and Blue Grass Airport's new community hangar for the airport's ...
N,N'-Diisopropylcarbodiimide (DIC) was purchased from CreoSalus (Louisville, KY). Piperidine was obtained from Alfa Aesar (Ward Hill, MA).
(Geisler left in 2010 to become COO and CFO at Creosalus, a Kentucky-based life-science company.) It was very hard to leave Verizon and its ...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.9M | 15 | 15% | $200M |
#2 | $0.6M | 15 | 0% | $4.3M |
#3 | $3.7M | 15 | -12% | N/A |
#4 | $1.3M | 15 | N/A | N/A |
#5 | $1.3M | 15 | N/A | N/A |